![](/img/cover-not-exists.png)
PCV157 COST-EFFECTIVENESS OF RIVAROXABAN 2.5 MG BID WITH ASA VERSUS ASA MONOTHERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE OR PERIPHERAL ARTERY DISEASE IN SLOVAKIA
Psota, M., Psenkova, M., Briere, J.B., Bowrin, K., Millier, A., Paulis, L., Krockova, R.Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.881
Date:
November, 2019
File:
PDF, 323 KB
english, 2019